Drug Shortage Report for ACT DILTIAZEM T

Last updated on 2018-10-11 History
Report ID 3362
Drug Identification Number 02370522
Brand name ACT DILTIAZEM T
Common or Proper name DILTIAZEM
Company Name ACTAVIS PHARMA COMPANY
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 360MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-06-30
Estimated end date 2018-09-20
Actual end date 2018-09-30
Shortage status Resolved
Updated date 2018-10-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-10-11 French Compare
v8 2018-10-11 English Compare
v7 2017-09-19 French Compare
v6 2017-09-19 English Compare
v5 2017-05-10 French Compare
v4 2017-05-10 English Compare
v3 2017-03-18 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare